IDenta Corp. (IDTA)

Market Cap	1.68M
Revenue (ttm)	1.20M
Net Income (ttm)	25.75K
Shares Out	4.05M
EPS (ttm)	0.01
PE Ratio	65.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	3,581
Open	0.4599
Previous Close	0.4150
Day's Range	0.4599 - 0.4599
52-Week Range	0.2620 - 0.8900
Beta	2.84
RSI	47.36
Earnings Date	May 13, 2025

About IDenta

IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Nigeria, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2002
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDTA

Financial Performance

In 2024, IDenta's revenue was $1.46 million, an increase of 38.41% compared to the previous year's $1.05 million. Earnings were $258,343, an increase of 1664.16%.